Prostate Cancer Clinical Trials

Prostate Cancer Clinical Trials

Prostate Cancer Clinical Trials Contact Us 1) First Line Metastatic mCRPC: USO #19191: BMS CA209-7DX: A Phase 3 Randomized, Double-Blind Study of Nivolumab or Placebo in Combination with Docetaxel, in Men with Metastatic Castration-resistant Prostate Cancer...
Multiple Myeloma Clinical Trials

Multiple Myeloma Clinical Trials

Multiple Myeloma Clinical Trials Contact Us 1)Relapsed/Refractory MM/ IONA: A prospective, non-interventional, multinational, observational study with Isatuximab in patients with relapsed and/or refractory multiple myeloma (RRMM) Send UsA Message LOCATION* ---WEST...
Colorectal Cancer Clinical Trials

Colorectal Cancer Clinical Trials

Colorectal CancerClinical Trials Contact Us 1) Phase 1B single agent cohort part of Mirati 849-001/USO 19151: Cohort F – A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation CRC with KRAS G12C...
Breast Cancer Clinical Trials

Breast Cancer Clinical Trials

Breast CancerClinical Trials Contact Us 1) Up to 3 lines of post-adjuvant or neoadjuvant therapy for TNBC/AYALA: AL-TNBC-01: A Phase 2, Multicenter, Open-label study of AL101 Monotherapy in Patients with Notch Activated Recurrent or Metastatic Triple Negative Breast...
Lymphoma Clinical Trials

Lymphoma Clinical Trials

Lymphoma Clinical Trials Contact Us DIFFUSE LARGE B-CELL LYMPHOMA: (4) 1) 2ND line or greater/ SGN35-031: A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination with Lenalidomide...
Call Now Button